Home > Press > AMETEK Acquires Sterling Ultra Precision
Abstract:
Acquisition Strengthens AMETEK's Position in Niche Ophthalmic Lens Market
AMETEK, Inc. (NYSE: AME) announced it has acquired the assets of Sterling Ultra Precision, a privately held reseller of machine tools for the ophthalmic lens market. Sterling Ultra Precision is headquartered in Tampa, FL.
"The acquisition of Sterling Ultra Precision provides us with an attractive opportunity to further broaden our capabilities and position in the niche ophthalmic lens market," comments Frank S. Hermance, AMETEK Chairman and Chief Executive Officer. "Sterling currently bundles AMETEK's Precitech Optoform machine tools with proprietary software and specialty fixtures that are used in the design and manufacture of contact lenses, contact lens molds and intraocular lenses."
"Our Precitech business has a long-standing relationship with Sterling, which enjoys strong brand recognition, large customer base and excellent market share in the ophthalmic lens market. By acquiring Sterling, we gain direct access to a highly profitable niche market that has excellent growth opportunities worldwide," adds Mr. Hermance.
Acquired in 2006, AMETEK's Precitech business is a leader in ultra-precision machining systems for applications requiring nano-metric levels of accuracy. Its Optoform machine tool systems are designed specifically for the high-speed lathing of spherical, multi-curve or aspheric contact and intraocular lenses.
Precitech is a unit of AMETEK Ultra Precision Technologies, which also includes AMETEK's Taylor Hobson and Solartron Metrology businesses, which provide high-end metrology instruments used in a wide variety of ultra-precise manufacturing and nanotechnology applications.
Forward-looking Information
Statements in this news release relating to future events such as AMETEK's expected business and financial performance are "forward-looking statements." Forward-looking statements are subject to various factors and uncertainties that may cause actual results to differ significantly from expectations. These factors and uncertainties include our ability to consummate and successfully integrate future acquisitions; risks associated with international sales and operations; our ability to successfully develop new products, open new facilities or transfer product lines; the price and availability of raw materials; compliance with government regulations, including environmental regulations; changes in the competitive environment or the effects of competition in our markets; the ability to maintain adequate liquidity and financing sources; and general economic conditions affecting the industries we serve. A detailed discussion of these and other factors that may affect our future results is contained in AMETEK's filings with the Securities and Exchange Commission, including its most recent reports on Form 10-K, 10-Q and 8-K. AMETEK disclaims any intention or obligation to update or revise any forward-looking statements.
####
About AMETEK
AMETEK is a leading global manufacturer of electronic instruments and electromechanical devices with annual sales of $2.1 billion. AMETEK's Corporate Growth Plan is based on Four Key Strategies: Operational Excellence, Strategic Acquisitions & Alliances, Global & Market Expansion and New Products. AMETEK's objective is double-digit percentage growth in earnings per share over the business cycle and a superior return on total capital. The common stock of AMETEK is a component of the S&P MidCap 400 Index and the Russell 1000 Index.
For more information, please click here
Contacts:
William J. Burke
(610) 889-5249
Copyright © PrNewswire
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Tools
Turning up the signal November 8th, 2024
Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024
Faster than one pixel at a time – new imaging method for neutral atomic beam microscopes developed by Swansea researchers August 16th, 2024
Acquisitions/Mergers/Splits
180 Degree Capital Corp. Life Science Portfolio Company Enters Into Definitive Agreement to be Acquired May 6th, 2020
180 Degree Capital Corp.’s Portfolio Company, Synacor, Inc., Agrees to Merge with Qumu Corporation in All-Stock Transaction February 11th, 2020
Combination of Nanometrics and Rudolph Technologies to Create Onto Innovation October 16th, 2019
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||